Jundishapur Journal of Microbiology

Published by: Kowsar

Molecular Characterization of Pre-Core/Core and S Region of Hepatitis B Virus in Hemodialysis Patients With Occult Hepatitis B Infection

Nasrin Rastegarvand 1 , 2 , Manoochehr Makvandi 1 , 2 , * , Alireza Samarbafzadeh 1 , 2 , Mojtaba Rasti 1 , Niloofar Neisi 2 , Amir Pouremamali 2 , Ali Teimoori 2 and Abdolnabi Shabani 2
Authors Information
1 Infectious and Tropical Disease Research Center, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Department of Virology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
Article information
  • Jundishapur Journal of Microbiology: October 01, 2015, 8 (10); e23686
  • Published Online: October 26, 2015
  • Article Type: Research Article
  • Received: September 16, 2014
  • Revised: March 6, 2015
  • Accepted: April 22, 2015
  • DOI: 10.5812/jjm.23686

To Cite: Rastegarvand N, Makvandi M, Samarbafzadeh A, Rasti M, Neisi N, et al. Molecular Characterization of Pre-Core/Core and S Region of Hepatitis B Virus in Hemodialysis Patients With Occult Hepatitis B Infection, Jundishapur J Microbiol. 2015 ; 8(10):e23686. doi: 10.5812/jjm.23686.

Abstract
Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Hamidi-Fard M, Makvandi M, Samarbaf-Zadeh A, Hajiani E, Shayesteh A, Masjedizadeh A. Mutation analysis of hepatitis B virus reverse transcriptase region among untreated chronically infected patients in Ahvaz city (South-West of Iran). Indian J Med Microbiol. 2013; 31(4): 360-5[DOI][PubMed]
  • 2. Ramezani A, Banifazl M, Mamishi S, Sofian M, Eslamifar A, Aghakhani A. The influence of human leukocyte antigen and IL-10 gene polymorphisms on hepatitis B virus outcome. Hepat Mon. 2012; 12(5): 320-5[DOI][PubMed]
  • 3. Arababadi MK, Nasiri Ahmadabadi B, Yousefi Daredor H, Kennedy D. Epidemiology of occult hepatitis B infection among thalassemic, hemophilia, and hemodialysis patients. Hepat Mon. 2012; 12(5): 315-9[DOI][PubMed]
  • 4. Shavakhi A, Norinayer B, Esteghamat FS, Seghatoleslami M, Khodadustan M, Somi MH, et al. Occult hepatitis B among Iranian hepatitis C patients. J Res Med Sci. 2009; 14(1): 13-7[PubMed]
  • 5. Chen SJ, Zhao YX, Fang Y, Xu WZ, Ma YX, Song ZW, et al. Viral deletions among healthy young Chinese adults with occult hepatitis B virus infection. Virus Res. 2012; 163(1): 197-201[DOI][PubMed]
  • 6. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat. 2002; 9(4): 243-57[PubMed]
  • 7. Shahmoradi S, Yahyapour Y, Mahmoodi M, Alavian SM, Fazeli Z, Jazayeri SM. High prevalence of occult hepatitis B virus infection in children born to HBsAg-positive mothers despite prophylaxis with hepatitis B vaccination and HBIG. J Hepatol. 2012; 57(3): 515-21[DOI][PubMed]
  • 8. Zuckerman AJ. Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet. 2000; 355(9213): 1382-4[DOI][PubMed]
  • 9. Ackerman Z, Wands JR, Gazitt Y, Brechot C, Kew MC, Shouval D. Enhancement of HBsAg detection in serum of patients with chronic liver disease following removal of circulating immune complexes. J Hepatol. 1994; 20(3): 398-404[PubMed]
  • 10. Chemin I, Zoulim F, Merle P, Arkhis A, Chevallier M, Kay A, et al. High incidence of hepatitis B infections among chronic hepatitis cases of unknown aetiology. J Hepatol. 2001; 34(3): 447-54[PubMed]
  • 11. Hamkar R, Aghakhani A, Soufian S, Banifazl M, Ghavami N, Nadri M, et al. Surface gene mutations of hepatitis B virus among high-risk patients with occult hepatitis B virus infection. Diagn Microbiol Infect Dis. 2010; 66(3): 285-91[DOI][PubMed]
  • 12. Jafarzadeh A, Kazem iArababadi M, Mirzaee M, Pourazar A. Occult hepatitis B virus infection among blood donors with antibodies to hepatitis B core antigen. Acta Med Iran. 2008; 46(1): 27-32
  • 13. Aghakhani A, Banifazl M, Velayati AA, Eslamifar A, Ramezani A. Occult hepatitis B virus infection in hemodialysis patients: a concept for consideration. Ther Apher Dial. 2012; 16(4): 328-33[DOI][PubMed]
  • 14. Arababadi MK, Hassanshahi G, Pourfathollah AA, Zarandi ER, Kennedy D. Post-transfusion occult hepatitis B (OBI): a global challenge for blood recipients and health authorities. Hepat Mon. 2011; 11(9): 714-8[DOI][PubMed]
  • 15. Kumar GT, Kazim SN, Kumar M, Hissar S, Chauhan R, Basir SF, et al. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection. J Gastroenterol Hepatol. 2009; 24(4): 588-98[DOI][PubMed]
  • 16. Arababadi MK, Mohammadzadeh A, Pourfathollah AA, Kennedy D. Polymorphisms within Fas gene are not associated with occult hepatitis B virus infection: Polymorphisms within Fas gene in occult HBV infection. Hepat Mon. 2011; 11(1): 23-6[PubMed]
  • 17. Bruni R, Prosperi M, Marcantonio C, Amadori A, Villano U, Tritarelli E, et al. A computational approach to identify point mutations associated with occult hepatitis B: significant mutations affect coding regions but not regulative elements of HBV. Virol J. 2011; 8: 394[DOI][PubMed]
  • 18. Torbenson M, Thomas DL. Occult hepatitis B. Lanc Infect Dis. 2002; 2(8): 479-86[DOI]
  • 19. Aghakhani A, Banifazl M, Kalantar E, Eslamifar A, Ahmadi F, Razeghi E, et al. Occult hepatitis B virus infection in hemodialysis patients with isolated hepatitis B core antibody: a multicenter study. Ther Apher Dial. 2010; 14(3): 349-53[DOI][PubMed]
  • 20. Besharat S, Katoonizadeh A, Moradi A. Potential mutations associated with occult hepatitis B virus status. Hepat Mon. 2014; 14(5)[DOI][PubMed]
  • 21. Keyvani H, Agah S, Kabir A, Alavian SM. Prevalence and risk factors of isolated anti-HBc antibody and occult hepatitis B infection in hemodialysis patients: a nationwide study. Ann Hepatol. 2013; 12(2): 213-9[PubMed]
  • 22. Abu El Makarem MA, Abdel Hamid M, Abdel Aleem A, Ali A, Shatat M, Sayed D, et al. Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infection. Hepat Mon. 2012; 12(4): 253-8[DOI][PubMed]
  • 23. Alavian SM. Occult hepatitis B virus infection among hemodialysis patients. Hepat Mon. 2012; 12(4): 242-3[DOI][PubMed]
  • 24. Nainan OV, Khristova ML, Byun K, Xia G, Taylor PE, Stevens CE, et al. Genetic variation of hepatitis B surface antigen coding region among infants with chronic hepatitis B virus infection. J Med Virol. 2002; 68(3): 319-27[DOI][PubMed]
  • 25. Gerlich WH. Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. J Clin Virol. 2006; 36 Suppl 1-22[PubMed]
  • 26. Sayan M, Senturk O, Akhan SC, Hulagu S, Cekmen MB. Monitoring of hepatitis B virus surface antigen escape mutations and concomitantly nucleos(t)ide analog resistance mutations in Turkish patients with chronic hepatitis B. Int J Infect Dis. 2010; 14 Suppl 3-41[DOI][PubMed]
  • 27. Jeantet D, Chemin I, Mandrand B, Tran A, Zoulim F, Merle P, et al. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. J Med Virol. 2004; 73(4): 508-15[DOI][PubMed]
  • 28. Minuk GY, Sun DF, Greenberg R, Zhang M, Hawkins K, Uhanova J, et al. Occult hepatitis B virus infection in a North American adult hemodialysis patient population. Hepatology. 2004; 40(5): 1072-7[DOI][PubMed]
  • 29. Mu SC, Lin YM, Jow GM, Chen BF. Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan. J Hepatol. 2009; 50(2): 264-72[DOI][PubMed]
  • 30. Awerkiew S, Daumer M, Reiser M, Wend UC, Pfister H, Kaiser R, et al. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient. J Clin Virol. 2007; 38(1): 83-6[DOI][PubMed]
  • 31. Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, et al. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology. 2001; 34(5): 1027-34[DOI][PubMed]
  • 32. van Hemert FJ, Zaaijer HL, Berkhout B, Lukashov VV. Occult hepatitis B infection: an evolutionary scenario. Virol J. 2008; 5: 146[DOI][PubMed]
  • 33. Zaaijer HL, van Hemert FJ, Koppelman MH, Lukashov VV. Independent evolution of overlapping polymerase and surface protein genes of hepatitis B virus. J Gen Virol. 2007; 88: 2137-43[DOI][PubMed]
  • 34. Bremer CM, Saniewski M, Wend UC, Torres P, Lelie N, Gerlich WH, et al. Transient occult hepatitis B virus infection in a blood donor with high viremia. Transfusion. 2009; 49(8): 1621-9[DOI][PubMed]
  • 35. Rios-Ocampo WA, Cortes-Mancera F, Olarte JC, Soto A, Navas MC. Occult hepatitis B virus infection among blood donors in Colombia. Virol J. 2014; 11: 206[DOI][PubMed]
  • 36. Ghabeshi S, Sharifi Z, Hosseini SM, Mahmoodian Shooshtari M. Correlation between viral load of HBV in chronic hepatitis B patients and precore and Basal core promoter mutations. Hepat Mon. 2013; 13(2)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments